Drug Information

Drug General Information
Drug ID
D07HAD
Former ID
DCL001016
Drug Name
Telbermin
Synonyms
Telbermin (USAN/INN)
Indication Diabetic foot ulcer [ICD9: 707; ICD10:L88-L89] Discontinued in Phase 2 [536297]
Company
Genentech
CAS Number
CAS 205887-54-3
PubChem Substance ID
47207716
Target and Pathway
Target(s) Vascular endothelial growth factor receptor 1 Target Info Activator [536297]
KEGG Pathway Ras signaling pathway
Rap1 signaling pathway
Cytokine-cytokine receptor interaction
HIF-1 signaling pathway
Endocytosis
PI3K-Akt signaling pathway
Focal adhesion
Transcriptional misregulation in cancer
Rheumatoid arthritis
Pathway Interaction Database Glypican 1 network
HIF-2-alpha transcription factor network
S1P3 pathway
VEGF and VEGFR signaling network
VEGFR1 specific signals
Signaling events mediated by VEGFR1 and VEGFR2
Reactome Neurophilin interactions with VEGF and VEGFR
VEGF binds to VEGFR leading to receptor dimerization
WikiPathways Focal Adhesion
Signaling by VEGF
Angiogenesis
References
Ref 536297Emerging drugs for diabetic foot ulcers. Expert Opin Emerg Drugs. 2006 Nov;11(4):709-24.
Ref 536297Emerging drugs for diabetic foot ulcers. Expert Opin Emerg Drugs. 2006 Nov;11(4):709-24.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.